Los medicamentos GLP-1 fueron desarrollados originalmente para tratar la diabetes tipo 2, pero su eficacia en la reduccin del peso llev a que organismos reguladores amplen su uso en pacientes con obesidad
Salem V, Izzi-Engbeaya C, Coello C et al (2016) Glucagon increases energy expenditure independently of brown adipose tissue activation in humans
After you have removed the needle, place the pen cap back on your pen
Patients should maintain 1.5-2 litres of fluid daily and monitor urine colour as a hydration indicator
Investigations to consider: U&Es, FBC, Blood glucose TFTs, B12 can be considered if diagnosis is uncertain Morning (9am) cortisol, if suspicion of adrenal insufficiency ECG Other investigations: Echo, if clinical evidence of structural heart disease (eg heart failure or valvular pathology) Ambulatory ECG monitoring for patients with suspected cardiac arrhythmia (eg sudden loss of consciousness with prompt recovery, unrelated to posture and especially if occurring when supine
This makes it easier for people with busy lives to stay consistent with their treatment
